---
$id: https://graph.org.ai/products/commodity/51152028
$type: Product
source: UNSPSC
code: "51152028"
title: "Dotefonium"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dotefonium

**UNSPSC Code**: 51152028
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C20H27N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F41A22A3KV, chemically known as pyrrolidinium, 1-methyl-1-(2-(n-methyl-alpha-2-thienylmandelamido)ethyl)- but generally known as dotefonium, which bears US NIH Compound Identifier 71913. European Medicines Agency schedules Dotefonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06379MIG. The term DOTEFONIUM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). As of Q4 2014, DOTEFONIUM remains the US FDA Preferred Term for this commodity. Dotefonium bears US NLM identifiers UMLS ID C2828324 and NCI Concept Code C87490. SMILES: CN(CC[N+]1(CCCC1)C)C(=O)C(C2=CC=CC=C2)(C3=CC=CS3)O.

